Literature DB >> 16415327

Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Christopher Lau1, Julie R Thibodeaux, Roger G Hanson, Michael G Narotsky, John M Rogers, Andrew B Lindstrom, Mark J Strynar.   

Abstract

Perfluorooctanoic acid (PFOA), a member of the perfluoroalkyl acids that have wide commercial applications, has recently been detected in humans and wildlife. The current study characterizes the developmental toxicity of PFOA in the mouse. Timed-pregnant CD-1 mice were given 1, 3, 5, 10, 20, or 40 mg/kg PFOA by oral gavage daily from gestational day (GD) 1 to 17; controls received an equivalent volume (10 ml/kg) of water. PFOA treatment produced dose-dependent full-litter resorptions; all dams in the 40-mg/kg group resorbed their litters. Weight gain in dams that carried pregnancy to term was significantly lower in the 20-mg/kg group. At GD 18, some dams were sacrificed for maternal and fetal examinations (group A), and the rest were treated once more with PFOA and allowed to give birth (group B). Postnatal survival, growth, and development of the offspring were monitored. PFOA induced enlarged liver in group A dams at all dosages, but did not alter the number of implantations. The percent of live fetuses was lower only in the 20-mg/kg group (74 vs. 94% in controls), and fetal weight was also significantly lower in this group. However, no significant increase in malformations was noted in any treatment group. The incidence of live birth in group B mice was significantly lowered by PFOA: ca. 70% for the 10- and 20-mg/kg groups compared to 96% for controls. Postnatal survival was severely compromised at 10 or 20 mg/kg, and moderately so at 5 mg/kg. Dose-dependent growth deficits were detected in all PFOA-treated litters except the 1-mg/kg group. Significant delays in eye-opening (up to 2-3 days) were noted at 5 mg/kg and higher dosages. Accelerated sexual maturation was observed in male offspring, but not in females. These data indicate maternal and developmental toxicity of PFOA in the mouse, leading to early pregnancy loss, compromised postnatal survival, delays in general growth and development, and sex-specific alterations in pubertal maturation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415327     DOI: 10.1093/toxsci/kfj105

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  102 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

2.  Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Authors:  Darlene Dixon; Casey E Reed; Alicia B Moore; Eugene A Gibbs-Flournoy; Erin P Hines; Elizabeth A Wallace; Jason P Stanko; Yi Lu; Wendy N Jefferson; Retha R Newbold; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2011-11-28       Impact factor: 3.143

3.  Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.

Authors:  Brianna N VanNoy; Juleen Lam; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2018-06

4.  The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Authors:  Deirdre K Tucker; Madisa B Macon; Mark J Strynar; Sonia Dagnino; Erik Andersen; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2014-12-12       Impact factor: 3.143

5.  Oxidative stress from diverse developmental neurotoxicants: antioxidants protect against lipid peroxidation without preventing cell loss.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2009-12-11       Impact factor: 3.763

6.  Perfluorooctanoate exposure and major birth defects.

Authors:  Cheryl R Stein; David A Savitz; Beth Elston; Phoebe G Thorpe; Suzanne M Gilboa
Journal:  Reprod Toxicol       Date:  2014-05-04       Impact factor: 3.143

7.  Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway.

Authors:  Charlotta Rylander; Magritt Brustad; Helena Falk; Torkjel M Sandanger
Journal:  J Environ Public Health       Date:  2010-01-06

8.  Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.

Authors:  Barbara D Abbott; Carmen R Wood; Andrew M Watkins; Kaberi P Das; Christopher S Lau
Journal:  PPAR Res       Date:  2010-07-26       Impact factor: 4.964

9.  Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha.

Authors:  Cynthia J Wolf; Robert D Zehr; Judy E Schmid; Christopher Lau; Barbara D Abbott
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

10.  Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.

Authors:  Noriaki Washino; Yasuaki Saijo; Seiko Sasaki; Shizue Kato; Susumu Ban; Kanae Konishi; Rie Ito; Ayako Nakata; Yusuke Iwasaki; Koichi Saito; Hiroyuki Nakazawa; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2008-11-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.